This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: F-Star Biotechnologische Forschungs- Und Entwicklungsges.m.b.h, Greenovation Biotech Gmbh, Meridian Biopharmaceuticals Gmbh. Active years: 2010-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rutzendorf, AT (2010 - 2012)
- Gross-Enzersdorf, AT (2014 - 2018)
Company Filing History:
6 out of 10 
2 out of 12 
2 out of 2 Years Active: 2010-2018
Title: Gerda Redl: Innovator in Cytotoxic Antibodies
Introduction
Gerda Redl is a prominent inventor based in Gross-Enzersdorf, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of cytotoxic antibodies. With a total of 8 patents to her name, her work has the potential to impact therapeutic applications significantly.
Latest Patents
One of her latest patents is focused on a cytotoxic immunoglobulin. This invention relates to a modular antibody with a molecular weight of up to 60 kD, specifically designed to bind to a cell surface target with a binding affinity of Kd < 10M. The patent also details a method for producing such antibodies and their therapeutic uses. Another notable patent involves the display of binding agents. This application describes a method for preparing a genetic package that displays oligomers of modular antibody domains that bind to a target and a scaffold ligand. It also includes vectors and libraries of genetic packages produced through this method, along with techniques for selecting suitable linker sequences for use in oligomer display.
Career Highlights
Throughout her career, Gerda has worked with notable companies in the biotechnology sector, including F-star Biotechnologische Forschungs- und Entwicklungsges.m.b.h. Her innovative work has positioned her as a key figure in her field.
Collaborations
Gerda has collaborated with esteemed colleagues such as Gottfried Himmler and Geert Mudde. These partnerships have further enhanced her research and development efforts.
Conclusion
Gerda Redl's contributions to the field of biotechnology, particularly in the area of cytotoxic antibodies, showcase her innovative spirit and dedication to advancing therapeutic solutions. Her work continues to inspire future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile